European News Update: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on European News Update.

Press releases published on September 8, 2026

Sep. 8, 2026

Greenland Mines Enters New Era as Rare Earths and Critical Minerals Company, Achieves Full Nasdaq Compliance and Sets Biotech Spin-Off for Q4

Indeterminate GlobeNewswire

Sep. 8, 2026

Veru Advances Oral Sabizabulin Following Positive Preclinical Data Showing Potent Anticancer Activity in Human Daraxonrasib (Revolution Medicines’ RASONQUE™) Resistant Pancreatic Cancer into a Planned Phase 2 Clinical Trial

Indeterminate GlobeNewswire

Sep. 8, 2026

GRI Bio Presents New Phase 2a Data at ERS 2026 Defining GRI-0621's Mechanism of Action in IPF Across Nine Mechanistic Pillars

Indeterminate GlobeNewswire

Sep. 8, 2026

Industrial Valve Training Programme Expanded with Interactive 3D Models, Video Lessons, and Component‑Level Walkthroughs

Indeterminate EIN Presswire

Sep. 8, 2026

Composition Notebook Market Industry Outlook Strengthens Amid Rising Global Demand

Indeterminate EIN Presswire

Sep. 8, 2026

Compressor Case Diver Market Value Expected To Grow At 6.9% CAGR, Reaching $1.93 Billion By 2030

Indeterminate EIN Presswire

Sep. 8, 2026

Dr. Gillian Cannon Joins Lindus Therapeutics’ Board as a Non-Executive Director

Indeterminate GlobeNewswire

Sep. 8, 2026

CPTx appoints Matt Kane as Chief Financial Officer

Indeterminate GlobeNewswire

Sep. 8, 2026

Renexxion to Present at H.C. Wainwright 28th Annual Global Investment Conference

Indeterminate GlobeNewswire

Sep. 8, 2026

Avalyn to Participate in the Morgan Stanley 24th Annual Global Healthcare Conference

Indeterminate GlobeNewswire

Sep. 8, 2026

Maxus Mining Expands Hurley West Antimony Project to Cover Historic Stibnite Prospect with Historical Results up to 16.9% Sb

Indeterminate GlobeNewswire

Sep. 8, 2026

Vaxart to Present at the H.C. Wainwright 28th Annual Global Investment Conference

Indeterminate GlobeNewswire

Sep. 8, 2026

Avalyn Presents New Data at ERS Congress 2026 Supporting AP01 Lung Distribution and Patient-Centered Trial Design in Pulmonary Fibrosis

Indeterminate GlobeNewswire

Sep. 8, 2026

Rani Therapeutics to Participate in Upcoming September Conferences

Indeterminate GlobeNewswire

Sep. 8, 2026

Structure Therapeutics Reports Positive Clinical Data Across Oral Small Molecule Amylin and GLP-1 Programs for Chronic Weight Management

Indeterminate GlobeNewswire

Sep. 8, 2026

BioAge Labs Announces First Participant Dosed in QUELL-DME, a Phase 2 Trial of BGE-102, a Novel Oral NLRP3 Inhibitor, in Diabetic Macular Edema

Indeterminate GlobeNewswire

Sep. 8, 2026

Niki BioSolutions to Participate in H.C. Wainwright's 28th Annual Global Investment Conference

Indeterminate GlobeNewswire

Sep. 8, 2026

Windward Bio announces positive Phase 2 results of WIN378 in asthma demonstrating significant improvements in lung function and airway inflammation with twice-yearly dosing, and initiates Phase 3

Indeterminate GlobeNewswire

Sep. 8, 2026

Clearmind Medicine Receives Yale IRB Approval, Enabling Patient Recruitment for Parts B and C of CMND-100 Phase I/II Trial, Following Positive Safety Results

Indeterminate GlobeNewswire

Sep. 8, 2026

Quantum Cyber Acquires NVIDIA A100 AI Compute Cluster to Power Its Swarm Operating System

Indeterminate GlobeNewswire